ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustryZurichHYLOMORPH AG
HYLOMORPH AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Hylomorph AG is the development and manufacture of innovative medical devices and drug-device combinations, particularly in the field of preventive medicine, with the aim of preventing complications during the implantation of medical devices and improving the health of patients after surgical interventions.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

HYLOMORPH AG

✓ Offered1
Antibiotic bioresorbable sheaths for CIEDs (Vesta)
Bioresorbable, antibiotic-eluting sheaths for cardiac implants such as pacemakers, ICDs and CRTs; device stabilization and local antibiotic delivery for infection prevention.
Trust & reputation

ranQ Trust Score of HYLOMORPH AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

HYLOMORPH AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
HYLOMORPH AG scores 86.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
HYLOMORPH AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
HYLOMORPH AG scores 60.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.71.44%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.50.04%
Qualifications+0.00

HYLOMORPH AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

September 5, 2023Media
Hylomorph secures CHF 4.5m ahead of market launch
startupticker.ch
December 3, 2021Media
Hylomorph secures CHF 5.2 million series-B round
startupticker.ch
June 7, 2021Media
Encouraging results from Hylomorph’s clinical trial
startupticker.ch
February 4, 2020Media
Hylomorphs Schutzhülle für Implantate erstem Patienten eingesetzt
startupticker.ch
August 30, 2018Media
CHF 3.2M in series A round for ETH spinoff Hylomorph
startupticker.ch

Knowledge

No knowledge articles yet

Once HYLOMORPH AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

HYLOMORPH AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank HYLOMORPH AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of HYLOMORPH AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Technoparkstrasse 1, DA 1017
8005 Zurich
Opening hours
Mon
24h
Tue
24h
Wed
24h
Thu
24h
Fri
24h
Sat
24h
Sun
24h

At a glance

Legal form
Corporation
UID
CHE-467.386.597
Founded
2014 · 12 years
Last commercial register change
August 7, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    MB
    MAST Biosurgery AG
    Zurich
    SF
    Surgical Fusion Technologies GmbH
    Schlieren
    BA
    Biotronik AG
    Bülach
    CG
    CosiDENT GmbH
    Zurich
    SA
    Scewo AG
    Winterthur
    CS
    Cordewener Schweiz AG
    Zurich
    PA
    Philips AG
    Horgen
    AG
    AtropaSwiss GmbH
    Dietlikon